SMi’s 4th Annual 3D Cell Culture Conference

Start Date : February 18, 2020
End Date : February 20, 2020
Time : 8:30 am to5:30 pm

Phone : 02078276000
Email : ssapal@smi-online.co.uk

Location :
Copthorne Tara Hotel London Kensington, Scarsdale Place, London, W8 5SY, United Kingdom

Website

Description

CHAIRED BY:


Philip Hewitt, UK and Eurotox Registered Toxicologist, Global Head of Early Investigative Toxicology, Merck Healthcare KGaA


Stefan Przyborski, Professor of Cell Technology, Durham university


 


Over the past few years, 3D Cell Culture has gained momentum within the pharmaceutical industry due to the benefits that this model offers for in vitro applications patient-derived tissues, drug discovery, predictivity and validation, and safety and toxicity.


 


SMi’s 3D Cell Culture Conference will explore advances of organ and lab-on-a-chip, microphysiological systems, applications of technology and case studies, imaging, high throughput screening and advances in 3D cell culture models which make up core components within the 3D Cell Culture field.


 


Bioprinting has become increasingly efficient and accurate in building in vitro tissue models with the potential to provide pathologically relevant responses and model human disease mechanisms. Bio-printed structures yield phenotypic endpoints that are comparable with clinical studies and can provide a realistic prediction of clinical efficacy. The use of bioprinting is growing in big pharma companies as an alternative to organ-on-a-chip systems.


 


For the first time ever the NEW 3D Bioprinting Focus Day on 18 February 2020 will explore case studies from big pharma, biotech’s and academia exploring how bioprinting is being used in industry highlighting projects looking at stem cell therapy, drug screening and extracellular matrix scaffolds.


 


WHO SHOULD ATTEND?


Biotech / Pharma Companies - Team Leader, Junior Principle investigator, Cell and Molecular Scientist, Chief Scientific Officer, Deputy Director, Manager, Founder, CEO, Head, Director, Programme Manager, Lab Head, Toxicologist


Academia Professor - Cell Technology, Stem Cell Sciences, Biochemistry, Protein Technology and Tissue Engineering


Solution Providers – Manager, Head of, CEO, Director, Founder, Account Manager, President, CSO, Executive, Managing Director


Ticketshttps://go.evvnt.com/520854-1?pid=3506


Brochure https://go.evvnt.com/520854-3?pid=3506


Inquiries https://go.evvnt.com/520854-4?pid=3506


Sponsorhttps://go.evvnt.com/520854-6?pid=3506


 


Prices:


Conference & Focus DayGBP 2398.00


Conference OnlyGBP 1499.00


Focus Day OnlyGBP 899.00


Promotional Literature Distribution at eventGBP 999.00


Documentation - Conference PresentationsGBP 499.00


Speakers: Petra Kerscher, Senior Scientist, Merck KGaA, Amna Magzoub, R&D Engineer, Novo Nordisk A/S Lars Growth Grunnet, Senior Scientist, Novo Nordisk, Stefan Przyborski, Professor of Cell Technology, University of Durham, Philip Hewitt, UK and Eutrotox Registered Toxicologist, Head of Early Investigative Technology, Merck, Amna Magzoub, R&D Engineer, Novo Nordisk A/S, Lars Growth Grunnet, Senior Scientist, Novo Nordisk, Sarah Trenfi eld, Director of Innovation, FabRx Ltd, Hansjoerg Keller, Senior Investigator I, Musculoskeletal Disease Area, Novartis, Jason Ekert, Head Complex In Vitro Models, GSK, Petra Kerscher, Senior Scientist, Merck, Hansjoerg Keller, Senior Investigator I, Novartis, Kenny Dalgarno, Professor of Manufacturing Engineering, Newcastle University Gino Van Heeke, CSO, Engitix, Naheem Yaqub, PhD Candidate, University College London in Collaboration with GSK, Veronique Barban, Expert Virology, Research and Nonclinical Safety Department, Sanofi Pasteur, Floriane Groell, Senior Scientist, Novartis Pharma AG, Samuel Jackson, Programme Manager, Disease Models Efficacy and Safety Pharmacology, NC3Rs, Kenny Dalgarno, Professor of Manufacturing Engineering, Newcastle University, Maxime Feyeux, Co-Founder, President, CSO, TreeFrog Therapeutics, Michele Zagnoni, Reader, University of Strathclyde, Leonard Both, Senior Quality Assessor, Biologicals/Biotechnology Unit, MHRA, Wendy Rowan, Scientific Director, Novel Human Genetics Research Unit, GSK, Alexander D. Graham, Investigator Scientist, MRC Harwell Institute, Ellen J. Wehrens, Scientific Writer, Imaging Department, Princess Máxima Center for Pediatric Oncology, Rajesh Pandey, Postdoctoral Training Fellow, MRC Harwell Institute

Registration Info

Register Now

 

Organized by

Organized by LoveEvvnt1

SMi Group


Event Categories: Health & Nutrition.




Your Review

You must be logged in to post a comment.